Mandolfo Salvatore, Maggio Milena, Forneris Giacomo, Galli Franco
UOC di Nefrologia e dialisi - Ospedale Maggiore Lodi.
UOC di Nefrologia e Dialisi - Centro di Ricerche di Immunopatologia e Documentazione Malattie Rare - Ospedale San Giovanni Bosco e Università di Torino.
G Ital Nefrol. 2019 Feb;36(1).
Catheter related bloodstream infections (CRBSI) represent a complication that often requires hospitalization and the use of economic resources. In Italy, there is no literature that considers the costs of CRBSI for tunneled catheters (CVCt). The aim of this work is to evaluate the relative costs of CRBSI through the DRG system. From 2012 to 2017 we examined 2.257 hospital discharge forms, 358 of which relating to haemodialysis patients. Patients with CVCt (167), compared to FAVs (157), on average stay in hospital longer (10 vs. 8 days), entail higher costs (+8.5%) and higher admissions rate for infections (+114%). The incidence of CRBSI was 0.67 episodes per 1000 CVCt/days. CRBSI accounts for 23% of the cases of hospitalization of patients with CVCt and 5.2% of total hospitalization costs. Complicated CRBSI involve a 9% increase in average costs compared to simple ones, with patients staying in hospital three times longer. The cost of a CRBSI varies from €4,080 up to €14,800, with an average cost of €5,575. The costs calculated here are less than a third of that reported in American literature but this can be explained by the different reimbursement rates systems. The methodology of CRBSI costs through DRGs appears simple, and its main limit is the correct compilation of the discharge form. This is a reminder that discharge forms are an integral part of the medical record and can become important in recognizing the cost of the medical services provided.
导管相关血流感染(CRBSI)是一种常常需要住院治疗并耗费经济资源的并发症。在意大利,尚无文献探讨隧道式导管(CVCt)引发的CRBSI成本。本研究旨在通过疾病诊断相关分组(DRG)系统评估CRBSI的相对成本。2012年至2017年期间,我们审查了2257份医院出院表格,其中358份与血液透析患者相关。使用CVCt的患者(167例)与使用动静脉内瘘(FAV)的患者(157例)相比,平均住院时间更长(分别为10天和8天),费用更高(高出8.5%),感染入院率更高(高出114%)。CRBSI的发生率为每1000个CVCt/日0.67例。CRBSI占CVCt患者住院病例的23%,占总住院费用的5.2%。复杂的CRBSI与简单的相比,平均费用增加9%,患者住院时间延长两倍。CRBSI的成本从4080欧元到14800欧元不等,平均成本为5575欧元。此处计算的成本不到美国文献报道成本的三分之一,但这可以用不同的报销费率系统来解释。通过DRG计算CRBSI成本的方法看似简单,其主要局限在于出院表格的正确填写。这提醒我们,出院表格是病历的重要组成部分,在认识所提供医疗服务的成本方面可能变得至关重要。